Beam Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $9,698 | $8,466 | $7,470 | $30,067 |
Gross Profit | -100,071 | -93,292 | -91,346 | -71,377 |
EBITDA | -107,168 | -114,613 | -113,758 | -94,594 |
EBIT | -112,728 | -120,151 | -119,286 | -100,037 |
Net Income | -112,728 | -102,291 | -109,270 | -90,354 |
Net Change In Cash | 9,698 | 8,466 | 7,470 | 30,067 |
Free Cash Flow | -86,490 | -79,586 | -106,949 | -79,335 |
Cash | 267,959 | 282,132 | 527,907 | 281,967 |
Basic Shares | 102,570 | 101,995 | 87,975 | 82,824 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $63,518 | $377,709 | $60,920 | $51,844 |
Gross Profit | -304,043 | 377,709 | -250,674 | -180,290 |
EBITDA | -393,643 | -146,954 | -324,332 | -230,061 |
EBIT | -415,568 | -176,485 | -338,479 | -237,512 |
Net Income | -376,742 | -132,527 | -289,088 | -370,638 |
Net Change In Cash | 63,518 | 377,709 | 60,920 | 51,844 |
Cost of Revenue | 395,729 | |||
Free Cash Flow | -356,192 | -182,927 | -26,424 | -113,079 |
Cash | 281,967 | 435,895 | 232,767 | 559,994 |
Basic Shares | 82,313 | 77,151 | 70,015 | 64,227 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.10 |
2025-06-30 | -$1 |
2025-03-31 | -$1.24 |
2024-12-31 | -$1.09 |
